• Careers
    • Open Positions
    • Postdoctoral Training
    • Internships
    • Immigration Services
  • Contact
    • Media Inquiries
  • Intranet
La Jolla Institute for Immunology
  • Research
    • Databases
      • Database of Immune Cell Epigenomics
      • Immune Epitope Database
    • Diseases (A-Z)
    • Licensing Opportunities
    • Initiatives
    • Publications
    • Research Centers
      • Center for Autoimmunity and Inflammation
      • Center for Cancer Immunotherapy
      • Center for Infectious Disease and Vaccine Research
    • Research Services
      • Bioinformatics
      • Clinical Studies
      • Cryo-EM
      • DLAC
      • Flow Cytometry
      • Histopathology
      • Immunometabolism
      • Microscopy & Histology
      • Next Generation Sequencing
    • Legal Affairs & IP
  • Labs
    • Ay Lab
    • Benedict Lab
    • Cheroutre Lab
    • Croft Lab
    • Crotty Lab
    • Grifoni Lab
    • Hedrick Lab
    • Hogan Lab
    • Kawakami Lab
    • Kronenberg Lab
    • Ley Lab
    • Lindestam Arlehamn Lab
    • Myers Lab
    • Peters Lab
    • Rao Lab
    • Saphire Lab
    • Schmiedel Lab
    • Schoenberger Lab
    • Sette Lab
    • Seumois Lab
    • Sharma Lab
    • Shresta Lab
    • Vijayanand Lab
    • Weiskopf Lab
  • News
    • Blog
    • Life Without Disease STORIES
    • Magazine
    • News
    • Videos
  • Events
    • Art Competition
    • Life Without Disease Event Series
    • Live from the Lab
    • Scientific Seminars
  • About Us
    • Overview
      • History
      • Institute Facts
    • Our Team
      • Leadership
      • Faculty
        • Emeriti
        • Clinical Associates
      • Board of Directors
      • Scientific Advisory Board
    • Inclusion, Diversity, Equity & Advocacy at LJI
  • Support
    • Overview
    • Giving Opportunities
      • The Tullie and Rickey Families SPARK Program
      • Center for Precision Immunotherapy
      • Together for Asthma
      • SURGE Program
    • Ways to Give
    • Vanguard Giving Society
    • Planned Giving
    • Advancement Team
    • Clinical Studies
    • DONATE
  • Careers
    • Open Positions
    • Postdoctoral Training
    • Postdoctoral Association
    • Internships
  • Contact
    • Media Inquiries
Support

Publications

Reset
Sep 12, 2022 Nat Commun
SREBP2-dependent lipid gene transcription enhances the infection of human dendritic cells by Zika virus.
Branche E, Wang YT, Viramontes KM, Valls Cuevas JM, Xie J, Ana-Sosa-Batiz F, Shafee N, Duttke SH, McMillan RE, Clark AE, Nguyen MN, Garretson AF, Crames JJ, Spann NJ, Zhu Z, Rich JN, Spector DH, Benner C, Shresta S, Carlin AF.
May 9, 2022 Pathogens
Acute-phase serum cytokine levels and correlation with clinical outcomes in children and adults with primary and secondary dengue virus infection in Myanmar between 2017 and 2019.
Nwe KM, Ngwe Tun MM, Myat TW, Sheng Ng CF, Htun MM, Lin H, Hom NS, Soe AM, Elong Ngono A, Hamano S, Morita K, Thant KZ, Shresta S, Thu HM, Moi ML.
Apr 12, 2022 Cell Rep
A zika virus mutation enhances transmission potential and confers escape from protective dengue virus immunity.
Regla-Nava JA, Wang YT, Fontes-Garfias CR, Liu Y, Syed T, Susantono M, Gonzalez A, Viramontes KM, Verma SK, Kim K, Landeras-Bueno S, Huang CT, Prigozhin DM, Gleeson JG, Terskikh AV, Shi PY, Shresta S.
Nov 1, 2021 Antiviral Res.
SARS-CoV-2 monoclonal antibodies with therapeutic potential: Broad neutralizing activity and No evidence of antibody-dependent enhancement.
Wang YT, Allen RD 3rd, Kim K, Shafee N, Gonzalez AJ, Nguyen MN, Valentine KM, Cao X, Lu L, Pai CI, Johnson S, Kerwin L, Zhou H, Zhang Y, Shresta S.
Sep 6, 2021 Front Immunol.
The ability of Zika virus intravenous immunoglobulin to protect from or enhance Zika virus disease.
Pinto AK, Hassert M, Han X, Barker D, Carnelley T, Branche E, Steffen TL, Stone ET, Geerling E, Viramontes KM, Nykiforuk C, Toth D, Shresta S, Kodihalli S, Brien JD.
Jun 16, 2021 Viruses.
Emergence of a novel dengue virus 3 (DENV-3) genotype-I coincident with increased DENV-3 cases in Yangon, Myanmar between 2017 and 2019.
Soe AM, Ngwe Tun MM, Nabeshima T, Myat TW, Htun MM, Lin H, Hom NS, Inoue S, Nwe KM, Aye LPP, Fukuta M, Thant KZ, Hasebe F, Morita K, Shresta S, Thu HM, Moi ML.
Jun 1, 2021 Biochem Pharmacol.
Animal models for SARS-Cov2/Covid19 research-A commentary.
Jarnagin K, Alvarez O, Shresta S, Webb DR.
May 5, 2021 Sci Rep.
Repeated exposure to dengue virus elicits robust cross neutralizing antibodies against Zika virus in residents of Northeastern Thailand.
Hattakam S, Elong Ngono A, McCauley M, Shresta S, Yamabhai M.
Jan 29, 2021 PLoS Pathog.
Human FcRn expression and Type I Interferon signaling control Echovirus 11 pathogenesis in mice.
Wells AI, Grimes KA, Kim K, Branche E, Bakkenist CJ, DePas WH, Shresta S, Coyne CB.
Jan 11, 2021 JCI Insight.
Zika virus oncolytic activity requires CD8+ T cells and is boosted by immune checkpoint blockade.
Nair S, Mazzoccoli L, Jash A, Govero J, Bais SS, Hu T, Fontes-Garfias CR, Shan C, Okada H, Shresta S, Rich JN, Shi PY, Diamond MS, Chheda MG.
Jan 1, 2021 Am J Trop Med Hyg.
Whole genome sequencing of dengue virus serotype 2 from two clinical isolates and serological profile of dengue in the 2015-2016 Nepal outbreak.
Manandhar KD, McCauley M, Gupta BP, Kurmi R, Adhikari A, Nguyen AV, Elong Ngono A, Zompi S, Sessions OM, Shresta S.
Oct 12, 2020 Am. J. Trop. Med. Hyg
Whole Genome Sequencing of Dengue Virus Serotype 2 from Two Clinical Isolates and AU3 AU2 Serological Profile of Dengue in the 2015–2016 Nepal Outbreak
Manandhar K, McCauley M, Gupta BP, Kurmi R, Adhikari A, Nguyen A, Ngono AE, Zompi S, Sessions O, Shresta S.
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • Contact Us
  • Careers
  • Terms & Conditions
  • Privacy Policy
La Jolla Institute for Immunology

contact@lji.org
9420 Athena Circle
La Jolla, CA 92037

Phone: +1 (858) 752-6500

© 2023 La Jolla Institute for Immunology. All rights reserved. LJI is a 501(c)(3) tax-exempt organization. Federal Tax ID Number 33-0328688






 

Location: